Dazetrader, FDA approval will not start at all if UHP can have its way. Hemoshit must not be even remotely medically viable or the process of approval would have been started many, many years ago. It isn't even sold for non Class 3 purposes in the third world. Not one single unit. That should tell everyone something. This whole UHP agenda is clearly nothing more than a debt absorption gravy train.
News 
Market Data 
Discover 
